SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLIN
- 1 May 1979
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 313 (8126), 1111-1114
- https://doi.org/10.1016/s0140-6736(79)91792-6
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbitsAtherosclerosis, 1978
- Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in manProstaglandins, 1978
- Anti-platelet action of intravenous infusion of prostacyclin in manThrombosis Research, 1978
- Circulatory and anti-platelet effects of intravenous prostacyclin in healthy menPharmacological Research Communications, 1978
- Generation of prostacyclin by lungs in vivo and its release into the arterial circulationNature, 1978
- Reversal of platelet aggregation by prostacyclinPharmacological Research Communications, 1978
- INTRAVENOUS PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASEThe Lancet, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- FEMORAL-ARTERY INFUSION OF PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASEThe Lancet, 1973
- MEASUREMENT OF BLOOD-FLOW THROUGH SKELETAL MUSCLE BY INTRAMUSCULAR INJECTION OF XENON-133The Lancet, 1964